[Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)]
- PMID: 25926567
[Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)]
Abstract
Chronic kidney disease-mineral and bone disorder (CKD-MBD), is sequential pathophysiology that starts in the very early stages of CKD. Three major aspects of CKD-MBD are laboratory abnormalities, bone abnormalities and vascular calcification. In dialysis patients, the prevalence of death due to cardiovascular disease accounts for more than 40% of all-cause mortality. Therefore, arteriosclerosis with vascular calcification may be an important pathophysiological mechanism in the development of cardiovascular disease. Vascular calcification is known to be an important risk factor influencing mortality in CKD patients. A number of studies have suggested a close association between serum FGF23 concentration and the risks of mortality, cardiovascular disease vascular calcification as well as CKD progression. Renal insufficiency leads to decline in klotho level and impaired phosphate excretion. However serum phosphate levels are maintained in the normal range by up regulation of FGF23 and PTH in early CKD stage. Early treatment intervention is necessary to improve the prognosis of the CKD patient.
Similar articles
-
[Bone mineral metabolism in patients with chronic kidney disease: review of its pathophysiology and morbimortality].Rev Peru Med Exp Salud Publica. 2015 Apr-Jun;32(2):326-34. Rev Peru Med Exp Salud Publica. 2015. PMID: 26338395 Review. Spanish.
-
Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.Kidney Int. 2014 Jan;85(1):142-50. doi: 10.1038/ki.2013.271. Epub 2013 Jul 24. Kidney Int. 2014. PMID: 23884339 Free PMC article.
-
Klotho/FGF23 Axis in CKD.Contrib Nephrol. 2015;185:56-65. doi: 10.1159/000380970. Epub 2015 May 19. Contrib Nephrol. 2015. PMID: 26023015 Review.
-
Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?Semin Nephrol. 2014 Mar;34(2):151-63. doi: 10.1016/j.semnephrol.2014.02.007. Epub 2014 Feb 18. Semin Nephrol. 2014. PMID: 24780470 Review.
-
Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications.Nefrologia. 2016 Jul-Aug;36(4):368-75. doi: 10.1016/j.nefro.2016.01.011. Epub 2016 Apr 23. Nefrologia. 2016. PMID: 27118192 Review. English, Spanish.
Cited by
-
Cinacalcet versus standard treatment for chronic kidney disease: a protocol for a systematic review and meta-analysis.Syst Rev. 2016 Jan 4;5:2. doi: 10.1186/s13643-015-0177-1. Syst Rev. 2016. PMID: 26729302 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical